As the president and CEO of Vir Biotechnology, as well as in his role as head of BIO’s Coronavirus Collaboration Initiative, George Scangos has emerged as a global leader in the fight against COVID-19. In this conversation with Stanford structural biology professor Jody Puglisi, Dr. Scangos explains the challenge of building financially viable therapies for infectious diseases, talks about the current status of COVID-related research, and explores how to build an innovative and meaningful career in biotech.
Related

Video
Innovation
Building Better Online Communities [Entire Talk]
Sarah Friar, Nextdoor
49 minutes

Video
Innovation
The Language of Technology [Entire Talk]
Ravi Mhatre, Lightspeed Venture Partners
45 minutes

Video
Innovation
Making a Difference in Biotech [Entire Talk]
George Scangos, Vir Biotechnology
44 minutes

Video
Innovation
Innovating for Equity [Entire Talk]
Adam Pisoni, Abl Schools
48 minutes